Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

  • Posted on 2 July, 2024
    This video features an interview hosted by Global Health Youth Connect with Professor Adam Vogel called Interview with Experts.The conversation...
    • Posted on 21 June, 2024
      In this study, Thayabaran Kathiresan, Redenlab’s Director of Audio Engineering, co-authors "Cortical-striatal brain network distinguishes deepfake from real speaker identity”....
      • Posted on 7 June, 2024
        Displayed at 95 Horatio Street, NY, PWSC argues that stuttering fosters deep listening and collaboration, aiming to transform social reality...